These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2017195)

  • 21. Use of synthetic peptides to map antigenic sites of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Abens J; Undén A; Bartfai T
    J Infect Dis; 1988 Apr; 157(4):738-42. PubMed ID: 2450153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies that inhibit ADP-ribosyltransferase but not NAD-glycohydrolase activity of pertussis toxin.
    Kaslow HR; Schlotterbeck JD; Kenimer JG
    Infect Immun; 1990 Mar; 58(3):746-52. PubMed ID: 2155182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
    Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
    Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of amino acid residues essential for the enzymatic activities of pertussis toxin.
    Locht C; Capiau C; Feron C
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3075-9. PubMed ID: 2470088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structures of pertussis toxin with NAD
    Sakari M; Tran MT; Rossjohn J; Pulliainen AT; Beddoe T; Littler DR
    J Biol Chem; 2022 May; 298(5):101892. PubMed ID: 35378130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activities of complete and truncated forms of pertussis toxin subunits S1 and S2 synthesized by Escherichia coli.
    Locht C; Cieplak W; Marchitto KS; Sato H; Keith JM
    Infect Immun; 1987 Nov; 55(11):2546-53. PubMed ID: 3117686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies against the enzymatic subunit of both pertussis and cholera toxins.
    Kenimer JG; Probst PG; Karpas AB; Burns DL; Kaslow HR
    Dev Biol Stand; 1991; 73():133-41. PubMed ID: 1778307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of antibodies elicited by immunization with pertussis toxin.
    Kaslow HR; Schlotterbeck JD; Gotto J
    Dev Biol Stand; 1991; 73():143-50. PubMed ID: 1778308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of monoclonal antibody to pertussis toxin on toxin activity.
    Sato H; Sato Y; Ito A; Ohishi I
    Infect Immun; 1987 Apr; 55(4):909-15. PubMed ID: 2435660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin.
    Lobet Y; Feron C; Dequesne G; Simoen E; Hauser P; Locht C
    J Exp Med; 1993 Jan; 177(1):79-87. PubMed ID: 8418210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural relationship between the S1 and S4 subunits of pertussis toxin.
    Sato H; Sato Y
    FEMS Microbiol Lett; 1994 Jan; 115(1):63-9. PubMed ID: 7510256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational study of a short Pertussis toxin T cell epitope incorporated in a multiple antigen peptide template by CD and two-dimensional NMR. Analysis of the structural effects on the activity of synthetic immunogens.
    Esposito G; Fogolari F; Viglino P; Cattarinussi S; De Magistris MT; Chiappinelli L; Pessi A
    Eur J Biochem; 1993 Oct; 217(1):171-87. PubMed ID: 7693460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping of linear B-cell epitopes of the S2 subunit of pertussis toxin.
    Schmidt W; Schmidt MA
    Infect Immun; 1989 Feb; 57(2):438-45. PubMed ID: 2463969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and immunological characterization of HPLC-purified pertussis toxin subunits.
    Chong P; Cockle S; Boux H; Klein M
    Biochem Cell Biol; 1991; 69(5-6):336-40. PubMed ID: 1654940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical analysis of mutations at tyrosine-98 of the S1 subunit of pertussis toxin.
    Xu Y; Barbieri JT
    Biochemistry; 1994 Feb; 33(6):1573-9. PubMed ID: 8312278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin.
    Antoine R; Locht C
    Infect Immun; 1990 Jun; 58(6):1518-26. PubMed ID: 2341166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and secretion of pertussis toxin subunit S1 in Bacillus subtilis.
    Runeberg-Nyman K; Engström O; Löfdahl S; Ylöstalo S; Sarvas M
    Microb Pathog; 1987 Dec; 3(6):461-8. PubMed ID: 2904640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies of the antigenic structure of two cross-reacting proteins, pertussis and cholera toxins, using synthetic peptides.
    Presentini R; Perin F; Ancilli G; Nucci D; Bartoloni A; Rappuoli R; Antoni G
    Mol Immunol; 1989 Jan; 26(1):95-100. PubMed ID: 2927400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity.
    Pizza M; Bartoloni A; Prugnola A; Silvestri S; Rappuoli R
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7521-5. PubMed ID: 2902632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The crystal structure of pertussis toxin.
    Stein PE; Boodhoo A; Armstrong GD; Cockle SA; Klein MH; Read RJ
    Structure; 1994 Jan; 2(1):45-57. PubMed ID: 8075982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.